1. Home
  2. SLRX vs STKH Comparison

SLRX vs STKH Comparison

Compare SLRX & STKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • STKH
  • Stock Information
  • Founded
  • SLRX N/A
  • STKH 2018
  • Country
  • SLRX United States
  • STKH Israel
  • Employees
  • SLRX N/A
  • STKH N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • STKH Packaged Foods
  • Sector
  • SLRX Health Care
  • STKH Consumer Staples
  • Exchange
  • SLRX Nasdaq
  • STKH Nasdaq
  • Market Cap
  • SLRX 2.1M
  • STKH 1.9M
  • IPO Year
  • SLRX N/A
  • STKH 2021
  • Fundamental
  • Price
  • SLRX $0.50
  • STKH $0.89
  • Analyst Decision
  • SLRX
  • STKH
  • Analyst Count
  • SLRX 0
  • STKH 0
  • Target Price
  • SLRX N/A
  • STKH N/A
  • AVG Volume (30 Days)
  • SLRX 6.2M
  • STKH 848.0K
  • Earning Date
  • SLRX 08-19-2025
  • STKH 08-29-2025
  • Dividend Yield
  • SLRX N/A
  • STKH N/A
  • EPS Growth
  • SLRX N/A
  • STKH N/A
  • EPS
  • SLRX N/A
  • STKH N/A
  • Revenue
  • SLRX N/A
  • STKH $10,000.00
  • Revenue This Year
  • SLRX N/A
  • STKH N/A
  • Revenue Next Year
  • SLRX N/A
  • STKH N/A
  • P/E Ratio
  • SLRX N/A
  • STKH N/A
  • Revenue Growth
  • SLRX N/A
  • STKH N/A
  • 52 Week Low
  • SLRX $0.45
  • STKH $0.80
  • 52 Week High
  • SLRX $7.20
  • STKH $17.20
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 37.62
  • STKH 36.31
  • Support Level
  • SLRX $0.59
  • STKH $0.80
  • Resistance Level
  • SLRX $2.31
  • STKH $0.92
  • Average True Range (ATR)
  • SLRX 0.18
  • STKH 0.12
  • MACD
  • SLRX -0.02
  • STKH 0.01
  • Stochastic Oscillator
  • SLRX 2.27
  • STKH 20.00

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

Share on Social Networks: